Acute Liver Failure: Molecular Actors in Liver–Adipose Tissue Interplay

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Tissues and Organs".

Deadline for manuscript submissions: 20 November 2025 | Viewed by 63

Special Issue Editor


E-Mail
Guest Editor
Clinica Medica 5, Department of Medicine—DIMED, Hospital-University of Padova, 35128 Padua, Italy
Interests: acute and chronic liver disease; liver regeneration molecular mechanism; role of gender in liver biology; role of the immune system in the pathophysiology of the liver; role of the metabolism in liver and adipose tissue biology deregulation; liver and cardiac fibrosis in animal models of obesity; P2X7R/NLRP3 inflammasome axis in type 2 diabetes and its vascular complications; molecular mechanism of fibrosis dis-homeostasis

Special Issue Information

Dear Colleagues,

Acute liver failure (ALF) represents a group of severe clinical syndromes in which the rapid deterioration of liver functions leads to jaundice, coagulopathy, and a high mortality rate. Current treatments include pharmacotherapy and artificial liver support, but their therapeutic efficacy is limited. The only valid treatment is liver transplantation, with its multiple limitations (i.e., donor shortage, immune rejection after transplantation, life-long immune-suppressants). Alternative molecular and clinical strategies are an unmet need for ALF. This condition has been extensively and deeply investigated over the years, attempting to clarify and identify the roles of several novel actors in the mechanism which leads to organ failure and, possibly, its mitigation. The emerging role of adipose tissue as an active endocrine organ is of prominent interest, both as an active inflammation regulator and a systemic buffer.

In this Special Issue of Cells, I invite you to contribute original research articles, reviews, or perspective manuscripts on all aspects related to “Acute Liver Failure: Molecular Actors in Liver–Adipose Tissue Interplay”, especially expert insights into mechanistic, functional, cellular, or biochemical aspects of this topic. Relevant topics include, but are not limited to, the following:

  • Cytokine signaling;
  • Chemokine function;
  • In vitro and in vivo models;
  • Immunology;
  • Extracellular matrix;
  • Inflammasome;
  • NASH/NAFLD;
  • Alcohol;
  • Hepatitis;
  • Microbiota;
  • Translational medicine.

Dr. Marika Crescenzi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • inflammasome
  • adipose tissue
  • acute liver injury
  • adipokines
  • liver macrophages
  • hepatic stellate cells
  • liver sinusoidal endothelial cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop